Literature DB >> 23774742

Impact of mild cognitive impairment on health-related quality of life in Parkinson's disease.

William Reginold1, Sarah Duff-Canning, Christopher Meaney, Melissa J Armstrong, Susan Fox, Brandon Rothberg, Cindy Zadikoff, Nancy Kennedy, David Gill, Paul Eslinger, Fred Marshall, Mark Mapstone, Kelvin L Chou, Carol Persad, Irene Litvan, Benjamin Mast, David Tang-Wai, Anthony E Lang, Connie Marras.   

Abstract

BACKGROUND/AIMS: To assess the impact of mild cognitive impairment (MCI) or cognitive decline on health-related quality of life (HR-QOL) in Parkinson's disease (PD).
METHODS: HR-QOL measured by the Parkinson Disease Quality of Life Questionnaire (PDQ-39), MCI according to Movement Disorder Society Task Force criteria and cognitive decline from premorbid baseline were assessed in non-demented PD patients at 6 movement disorder clinics.
RESULTS: Among 137 patients, after adjusting for education, gender, disease duration, and Movement Disorder Society Unified Parkinson's Disease Rating Scale total score, MCI was associated with worse scores within the PDQ-39 dimension of communication (p = 0.008). Subjects were divided into tertiles of cognitive decline from premorbid level. Scores in the dimension of stigma were worst in the second tertile of cognitive decline (p = 0.03). MCI was associated with worse social support scores in the second tertile of cognitive decline (p = 0.008).
CONCLUSION: MCI and cognitive decline from premorbid baseline are associated with reduced HR-QOL in communication, stigma, and social support domains. The cognitive decline from premorbid baseline modifies the association between MCI and HR-QOL in PD and knowing both will allow a better appreciation of difficulties patients face in daily life.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23774742     DOI: 10.1159/000350032

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  15 in total

1.  The cognition and emotional well-being indices of the Parkinson's disease questionnaire-39: what do they really measure?

Authors:  Jacob D Jones; Chris Hass; Paul Mangal; Jacob Lafo; Michael S Okun; Dawn Bowers
Journal:  Parkinsonism Relat Disord       Date:  2014-09-18       Impact factor: 4.891

2.  Evaluation of mild cognitive impairment subtypes in Parkinson's disease.

Authors:  Brenna A Cholerton; Cyrus P Zabetian; Jia Y Wan; Thomas J Montine; Joseph F Quinn; Ignacio F Mata; Kathryn A Chung; Amie Peterson; Alberto J Espay; Fredy J Revilla; Johnna Devoto; G Stennis Watson; Shu-Ching Hu; James B Leverenz; Karen L Edwards
Journal:  Mov Disord       Date:  2014-04-07       Impact factor: 10.338

Review 3.  Lewy Body Degenerations as Neuropsychiatric Disorders.

Authors:  Jared T Hinkle; Gregory M Pontone
Journal:  Psychiatr Clin North Am       Date:  2020-04-08

4.  Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.

Authors:  Achinoam Faust-Socher; Sarah Duff-Canning; Arthur Grabovsky; Melissa J Armstrong; Brandon Rothberg; Paul J Eslinger; Christopher A Meaney; Ruth B Schneider; David F Tang-Wai; Susan H Fox; Cindy Zadikoff; Nancy Kennedy; Kelvin L Chou; Carol Persad; Irene Litvan; Benjamin T Mast; Adam T Gerstenecker; Sandra Weintraub; William Reginold; Connie Marras
Journal:  Dement Geriatr Cogn Disord       Date:  2019-07-17       Impact factor: 2.959

5.  Impact of Mild Cognitive Impairment on Quality of Life in Young and Typical Onset Parkinson's Disease.

Authors:  Heather M Holden; Corrin N Schweer; Alexander I Tröster
Journal:  Mov Disord Clin Pract       Date:  2021-10-16

6.  Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Authors:  Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Epifanio Bagarinao; Noritaka Yoneyama; Aya Ogura; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Reiko Ohdake; Yasuhiro Tanaka; Takashi Tsuboi; Tomohiko Nakamura; Masaaki Hirayama; Mizuki Ito; Naoki Atsuta; Satoshi Maesawa; Shinji Naganawa; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

7.  Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.

Authors:  D Bäckström; M Eriksson Domellöf; G Granåsen; J Linder; S Mayans; E Elgh; H Zetterberg; K Blennow; L Forsgren
Journal:  Acta Neurol Scand       Date:  2017-09-04       Impact factor: 3.209

8.  Severity of mild cognitive impairment in early Parkinson's disease contributes to poorer quality of life.

Authors:  Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Tien K Khoo; David P Breen; Roger A Barker; Daniel Collerton; John-Paul Taylor; David J Burn
Journal:  Parkinsonism Relat Disord       Date:  2014-07-18       Impact factor: 4.891

Review 9.  Cognitive Training in Parkinson's Disease: A Review of Studies from 2000 to 2014.

Authors:  Daniel Glizer; Penny A MacDonald
Journal:  Parkinsons Dis       Date:  2016-09-05

10.  Salience Network and Depressive Severities in Parkinson's Disease with Mild Cognitive Impairment: A Structural Covariance Network Analysis.

Authors:  Ya-Ting Chang; Cheng-Hsien Lu; Ming-Kung Wu; Shih-Wei Hsu; Chi-Wei Huang; Wen-Neng Chang; Chia-Yi Lien; Jun-Jun Lee; Chiung-Chih Chang
Journal:  Front Aging Neurosci       Date:  2018-01-10       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.